Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LOS ANGELES, June 18, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Microsoft Corporation, (“Microsoft" or the "Company") (NASDAQ: MSFT) investors that the firm has initiated an...
-
NEW ORLEANS, June 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 26, 2026 to file lead plaintiff applications in a...
-
ATLANTA, June 18, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Embecta Corp. (“Embecta”) (NASDAQ: EMBC). The lawsuit alleges that Defendants made false and...
-
Augmentation de capital 2026 réservée aux adhérents du Plan d’Epargne Groupe et du Plan d’Epargne Groupe International Wendel Emetteur WendelMaché réglementé d’Euronext Paris - Compartiment A...
-
The market timing is hard to ignore. The risk attorneys face is in the headlines every week, and a growing number of courts now expect a documented review.
-
TORONTO, June 18, 2026 (GLOBE NEWSWIRE) -- Lysander Funds Limited (“Lysander”), the manager of Canso Credit Income Fund (the “Fund”) (TSX: PBY.UN), today announced that the Fund intends to commence...
-
TORONTO, 18 juin 2026 (GLOBE NEWSWIRE) -- Lysander Funds Limited (« Lysander »), gestionnaire du Canso Credit Income Fund (le « Fonds ») (TSX : PBY.UN), a annoncé aujourd’hui que le Fonds a...
-
RANCHO CORDOVA, Californie, 18 juin 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour un accord de collaboration avec Orphan Therapeutics Accelerator (OTXL), une organisation à but non lucratif...
-
RANCHO CORDOVA, Kalifornien, June 18, 2026 (GLOBE NEWSWIRE) -- SK pharmteco hat heute eine Kooperationsvereinbarung mit Orphan Therapeutics Accelerator (OTXL) bekannt gegeben. OTXL ist ein...
-
캘리포니아주 랜초코르도바, June 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco는 오늘 희귀질환 치료제 개발을 지원하는 비영리 바이오 전문 기관인 OTXL(Orphan Therapeutics Accelerator) 과 신규 치료제 프로그램 개발을 촉진하기 위한 협력 계약을 체결했다고 발표했다. 이번 전략적 파트너십은...